Vice President, Communication, Public Affairs and Advocacy, Europe

Revolution Medicines•Redwood City, CA

About The Position

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This position will lead the development and execution of oncology-focused Public Affairs, Communications, and Advocacy strategies for the Europe region, integrating policy, patient advocacy, and other stakeholder engagement. The VP will represent the company as a transformative oncology voice across Europe, influencing external policy, advocacy, and communication environments to accelerate access to innovation. Reporting to the SVP Head of Europe with a dotted line to the they ensure that the oncology public affairs strategy is aligned with regional business priorities and the rapidly evolving European policy landscape to enable effective collaboration within region, strong relationships with European institutions and policymakers, and productive engagement with cancer patient organizations and coalitions across Europe. Policy and Stakeholder Environment Map and assess the evolving oncology policy environment, particularly within Europe (institutions, national governments, payers, HTA bodies). Monitor EU legislative processes (e.g., Pharma Legislation reform, HTA Regulation implementation, Cancer Mission) and help assess impact on business. Identify key opportunities and risks to shape cancer care policy, access, and innovation. Act as the primary point of contact for European health policy stakeholders, ensuring the company has a consistent and influential presence. Develop company positions and help affiliates represent the company in trade and industry associations. Advocacy Strategy and Execution Design and implement comprehensive Public Affairs, Communications & Advocacy strategies for the oncology portfolio, ensuring integration with brand, access, and corporate strategies. Lead engagement with European institutions (European Commission, European Parliament, EMA, ECDC) on cancer-related policy and regulatory issues. Build and sustain strategic partnerships with European cancer patient organizations, medical societies, and alliances to strengthen advocacy impact. Ensure that the patient voice is embedded in decision-making and that patient organizations are supported as key partners in improving access and outcomes. External Thought Leadership and Media Relations In alignment with the company’s global efforts, position the company as a credible oncology innovator in the Europe region by shaping narratives on cancer policy, access, and innovation in European media and policy forums. Build and maintain trusted relationships with top-tier European and trade media, ensuring accurate representation of company positions and achievements. Oversee proactive and reactive media communications, including issue and crisis management, to protect and enhance the company’s reputation. Partner with Global Communications to ensure alignment of European external messaging with corporate narrative and media relations. Internal Communication Ensure internal messaging reflects external priorities, aligning employees around the company’s mission, oncology strategy, and advocacy efforts. Partner with HR and corporate functions to drive a strong internal culture of transparency, inclusion, and purpose.

Requirements

Degree in Law, Communications, Political Science, Public Health, Life Sciences, or related fields.
Minimum 15 years in Public Affairs, Communications & Advocacy, preferably in oncology or rare diseases.
Proven experience on enterprise leadership such as building and developing teams.
Strong ability to develop and deliver impactful public affairs, communication, or advocacy campaigns.
Excellent interpersonal, verbal, and written communication skills, including storytelling and policy translation for lay audiences.
Skilled in managing and influencing complex stakeholder environments and partnerships.
Deep understanding of the European healthcare policy and oncology landscape, with strong networks across institutions, cancer alliances, and advocacy groups.
Proven track record of engaging with patient organizations, industry associations, and policymakers to deliver tangible policy and access outcomes.
Experience in launching new oncology medicines and shaping policy to enable faster patient access.
Familiarity with reimbursement, HTA processes, and access barriers in oncology.

Nice To Haves

Fluent in English, other languages are considered advantageous.

Responsibilities

Map and assess the evolving oncology policy environment, particularly within Europe (institutions, national governments, payers, HTA bodies).
Monitor EU legislative processes (e.g., Pharma Legislation reform, HTA Regulation implementation, Cancer Mission) and help assess impact on business.
Identify key opportunities and risks to shape cancer care policy, access, and innovation.
Act as the primary point of contact for European health policy stakeholders, ensuring the company has a consistent and influential presence.
Develop company positions and help affiliates represent the company in trade and industry associations.
Design and implement comprehensive Public Affairs, Communications & Advocacy strategies for the oncology portfolio, ensuring integration with brand, access, and corporate strategies.
Lead engagement with European institutions (European Commission, European Parliament, EMA, ECDC) on cancer-related policy and regulatory issues.
Build and sustain strategic partnerships with European cancer patient organizations, medical societies, and alliances to strengthen advocacy impact.
Ensure that the patient voice is embedded in decision-making and that patient organizations are supported as key partners in improving access and outcomes.
In alignment with the company’s global efforts, position the company as a credible oncology innovator in the Europe region by shaping narratives on cancer policy, access, and innovation in European media and policy forums.
Build and maintain trusted relationships with top-tier European and trade media, ensuring accurate representation of company positions and achievements.
Oversee proactive and reactive media communications, including issue and crisis management, to protect and enhance the company’s reputation.
Partner with Global Communications to ensure alignment of European external messaging with corporate narrative and media relations.
Ensure internal messaging reflects external priorities, aligning employees around the company’s mission, oncology strategy, and advocacy efforts.
Partner with HR and corporate functions to drive a strong internal culture of transparency, inclusion, and purpose.